Privia Health Group, Inc. - stock earnings
PRVA Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 2.8 million USD | 440.8 million USD |
2023Q3 | 5.6 million USD | 417.3 million USD |
2023Q2 | 7.3 million USD | 413.4 million USD |
2023Q1 | 7.3 million USD | 386.3 million USD |
2022Q4 | 17.8 million USD | 364.4 million USD |
2022Q3 | 556000 USD | 342.9 million USD |
2022Q2 | -11.4 million USD | 335.5 million USD |
2022Q1 | -18.1 million USD | 313.8 million USD |
2021Q4 | -12.0 million USD | 275.3 million USD |
2021Q3 | -9.1 million USD | 251.5 million USD |
2021Q2 | -172.5 million USD | 225.8 million USD |
2021Q1 | 5.4 million USD | 213.6 million USD |
2020Q4 | 3.9 million USD | 213.7 million USD |
2020Q3 | 16.7 million USD | 207.2 million USD |
2020Q2 | 5.3 million USD | 183.3 million USD |
2020Q1 | 5.4 million USD | 212.9 million USD |
PRVA Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 23.1 million USD | 1.7 billion USD |
2022 | -12.1 million USD | 1.4 billion USD |
2021 | -190.6 million USD | 966.2 million USD |
2020 | 31.2 million USD | 817.1 million USD |
2019 | 8.2 million USD | 786.4 million USD |
2018 | -3.0 million USD | 657.6 million USD |
PRVA
Price: $19.08
52 week price:
Earnings Per Share: 0.19 USD
P/E Ratio: 65.28
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Volume: 404900
Market Capitalization: 2.2 billion